Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 4 sources · 10 days · First seen about 1 month ago · Last updated 23 days ago

Daewoong Pharmaceutical expansion in Indonesia

Overview

Daewoong Pharmaceutical is expanding its presence in the Indonesian market by aligning with upcoming mandatory Halal certification regulations. To facilitate this, the company has engaged with the Indonesia Food and Drug Authority (BPOM) and the Halal Product Assurance Agency (BPJPH) to discuss import requirements and labeling. The South Korean government is also supporting these efforts by seeking mutual recognition of Halal certificates.

As part of a long-term localization strategy, Daewoong is constructing a smart factory in Cikarang, aimed at achieving GMP approval by July 2027 to serve the ASEAN Halal market.

Regulatory cooperation has since progressed to include high-level visits from BPOM officials to Daewoong’s Magok R&D Center. These discussions have focused on strengthening communication regarding licensing, clinical trials, and product development, while highlighting the company’s ongoing collaborations with Indonesian research institutions in biotechnology and cell therapy.

Entities

Daewoong Pharmaceutical · Magok R&D Center · Taruna Ikrar · Indonesian Food and Drug Authority · Halal Product Assurance Agency

Timeline

23 days ago

[BUSINESS] 2 sources
Indonesian BPOM delegation visits Daewoong Pharmaceutical R&D center
An Indonesian Food and Drug Authority (BPOM) delegation visited Daewoong Pharmaceutical’s Magok R&D Center to discuss regulatory cooperation and biopharmaceutical R&D localization strategies.
about 1 month ago

[BUSINESS] 3 sources
Daewoong Pharmaceutical targets Indonesian Halal market
Daewoong Pharmaceutical is targeting the Indonesian Halal market by preparing for mandatory certification and constructing a smart factory in Cikarang to serve as an ASEAN production hub.

Sources

biotimes.co.kr · bokuennews.com · healthmedia.co.kr · thebionews.net